|
|
|||||||
|
Winter 2009 e-Newsletter |
![]() The Science of Healthier Aging |
||||||
| . |
Thoughts from AFAR - A Note from the Executive Director ____________________________________________ Thoughts from AFAR - A Note from the Executive Director As we embark on 2009, we have a great deal to be grateful for. The sustained support of our friends representing foundations, corporations, the National Institute on Aging, and generous individuals, has allowed us to stay the course in tough economic times. We believe that investing in aging research will provide solid growth, because the strength of AFAR’s investments is its people. And that never loses value. All the best for a happy, healthy, and prosperous new year.
![]() ____________________________________________ Corporate and Scientific Leaders Honored for their Contributions to Research on Aging Peter D. Meldrum, of Myriad Genetics, Christoph Westphal, MD, PhD, of Sirtris, and John W. Rowe, MD, of Columbia University, were among the honorees at the AFAR annual awards dinner that took place on October 6, 2008, at New York City’s Grand Hyatt. The event, which attracted some 180 people from the corporate, scientific, and foundation communities, as well as individual AFAR supporters, was held in conjunction with AFAR’s scientific conference, Aging and Cancer: Two Sides of the Same Coin. Both events raised more than $250,000 that will support AFAR’s flagship research grant program, which funds early-career scientists studying the biology of aging and age-related diseases and disorders. To read about our 2008 Research Grant recipients, click here. Other honorees included Arlan Richardson, PhD, of the University of Texas Health Science Center at San Antonio and Ana Maria Cuervo, MD, PhD, of the Albert Einstein College of Medicine.
![]() Honorees John W. Rowe, MD, Columbia University, Ana Maria Cuervo, MD, PhD, Albert Einstein College of Medicine, Christoph Westphal, MD, PhD, Sirtris, and Peter D. Meldrum, Myriad Genetics.
_____________________________________________ AFAR Hosts Conference on the Biology of Cancer
An overview of the conference proceedings can be found at www.afar.org/cancerconfproceedings.html. To receive emailed or printed copies, please contact Stacey Harris, director of communications at Stacey@afar.org or 212-703-9977. A full program listing can be found at www.afar.org/cancerconf.html. AFAR thanks conference organizers: board members Harvey Cohen, MD, George M. Martin, MD, Roger McCarter, PhD, Dick Sprott, PhD, and Fox Wetle, PhD, as well as Jean-Luc Vanderheyden, PhD, of GE Healthcare and Margaret Yu, MD, of Myriad Pharmaceuticals. The conference was sponsored by: an anonymous donor, Eli Lilly, The Ellison Medical Foundation, GE Healthcare, Glenn Foundation for Medical Research, Myriad Pharmaceuticals, Pfizer, and the 2008 Dorothy Dillon Eweson Lecture Series. The meeting was also supported by 1R13AG033508-01 from the National Institute on Aging, National Institutes of Health.
_____________________________________________ Spotlight On: The Glenn Foundation for Medical Research For more than two decades, the Glenn Foundation for Medical Research, founded by philanthropist Paul F. Glenn, has been a consistent and loyal supporter of AFAR. Recently, the Glenn Foundation committed $5 million to support the AFAR Research Grant Program and the Glenn/AFAR Breakthroughs in Gerontology (BIG) Awards. AFAR Research Grants provide start-up funding to scientists in the early phases of their careers, enabling them to study the basic mechanisms of aging, age-related diseases, and processes underlying common geriatric functional disorders. The BIG Awards support innovative higher-risk research that may offer significant promise of yielding transforming discoveries in the fundamental biology of aging that could lead to major new insights into the factors that regulate aging. [Read about the 2008 BIG award winners.] Paul Glenn had a remarkable vision about the promise of research on the biology of aging years before the field of aging research even became a field. Starting the Glenn Foundation for Medical Research in 1965 to direct much needed funds to scientists studying the basic mechanisms of aging processes, created awareness that such an area of scientific study was needed and existed. Glenn understood early on that the way to combat the diseases of aging was to focus on aging itself. His forward-thinking vision has set a precedent that has encouraged other foundation, corporate, government, and individual support for aging research. Why do forward-thinking people like Paul Glenn partner with AFAR? According to Paul Glenn, "AFAR is the only organization, other than the National Institutes of Health, that has a peer review capability of evaluating grant applications for research in the biology of aging." That peer review process ensures that only the highest quality research receives support. Led by Glenn Foundation president Mark R. Collins, many of the nation’s leading scientists in biogerontology owe their start to Glenn-supported AFAR grants. For more information about the work of the Glenn Foundation for Medical Research, visit their web site at www.glennfoundation.org.
_____________________________________________ 10 Reasons AFAR Remains a Good Value Even before the financial downturn, AFAR’s administrative costs have always been among the lowest in the nonprofit community. Ninety-five percent of every dollar AFAR spends support research, meetings for scientists to exchange new ideas and knowledge, and public education. AFAR does this by:
1. Keeping staff small.
_____________________________________________
Other News
|
||||||